OTCMKTS:OMGAQ Omega Therapeutics (OMGAQ) Stock Price, News & Analysis $0.0030 0.00 (0.00%) As of 09/25/2026 Add Compare Share Share Stock Analysis Stock AnalysisChartSEC Filings About Omega Therapeutics Stock (OTCMKTS:OMGAQ) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Omega Therapeutics alerts:Sign Up Key Stats Today's Range$0.0030▼$0.003050-Day Range N/A52-Week Range$0.00▼$1.69VolumeN/AAverage Volume215,590 shsMarket Capitalization$166.10 thousandP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview Omega Therapeutics, Inc. is a biotechnology company focused on developing medicines that regulate gene expression through epigenetic mechanisms. The company’s approach is based on the idea that gene activity can be selectively controlled without changing the underlying DNA sequence. Omega developed its proprietary Omega Epigenomic Programming platform to create precision therapies known as Epigenomic Controllers. These investigational medicines are designed to target disease-related gene programs and have been explored in areas including oncology, autoimmune disease and other serious conditions. The company’s research programs have included OTX-2002, an investigational therapy aimed at regulating MYC-driven cancer biology, as well as additional preclinical and clinical-stage candidates. Founded in 2016 and headquartered in Cambridge, Massachusetts, Omega Therapeutics conducted its research and development activities primarily in the United States. The company was associated with Flagship Pioneering and was led for several years by Mahesh Karande, who served as president and chief executive officer. Its programs remain investigational and are subject to clinical testing and regulatory review.AI Generated. May Contain Errors. Read More Receive OMGAQ Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Omega Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. OMGAQ Stock News HeadlinesOMGAQ - Omega Therapeutics Inc Executives | MorningstarAugust 5, 2025 | morningstar.comMOmega Therapeutics Inc (OMGAQ)March 5, 2025 | investing.comWATCH THIS BEFORE DECEMBER 8th!!James Altucher says a quiet government filing could reveal Elon Musk's biggest move yet, and almost nobody has noticed it. Altucher believes the filing could matter to as many as 1,806,000 Americans in the years ahead. He explains why Musk buried it and what it could mean, free of charge.September 28 at 1:00 AM | Paradigm Press (Ad)Huge distressed drugmaker seeks sale in Chapter 11 bankruptcyFebruary 27, 2025 | msn.comIntrommune Therapeutics Announces Publication of OMEGA Study in Peanut Allergic Adults in Annals of Allergy, Asthma & ImmunologyFebruary 19, 2025 | markets.businessinsider.comOmega Therapeutics secures $9.8M in DIP financingFebruary 14, 2025 | msn.comOmega Therapeutics announces board reshuffle and new directorJanuary 29, 2025 | msn.comOmega Therapeutics stock hits 52-week low at $0.52January 21, 2025 | msn.comSee More Headlines OMGAQ Stock Analysis - Frequently Asked Questions How have OMGAQ shares performed this year? Omega Therapeutics' stock was trading at $0.0030 at the beginning of 2026. Since then, OMGAQ shares have increased by 0.0% and is now trading at $0.0030. How were Omega Therapeutics' earnings last quarter? Omega Therapeutics, Inc. (OTCMKTS:OMGAQ) issued its quarterly earnings results on Tuesday, August, 6th. The company reported ($0.30) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.36) by $0.06. The business earned $2.13 million during the quarter, compared to the consensus estimate of $1.25 million. How do I buy shares of Omega Therapeutics? Shares of OMGAQ stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Company Calendar Last Earnings8/06/2024Today9/28/2026Fiscal Year End12/31/2026Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorHealthcare Industry Pharmaceuticals Sub-IndustryPharmaceuticals Current SymbolOTCMKTS:OMGAQ Previous SymbolNASDAQ:OMGA CIK1850838 Webwww.omegatherapeutics.com Phone617-949-4360FaxN/AEmployees120Year Founded2017Profitability EPS (Trailing Twelve Months)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual Sales$3.09 million Price / Sales0.05 Cash FlowN/A Price / Cash FlowN/A Book Value$1.05 per share Price / Book0.00Miscellaneous Outstanding Shares55,366,000Free Float50,660,000Market Cap$166.10 thousand OptionableNo Data Beta0.57 Social Links 7 Best Space Stocks to Own in 2026The space race is growing fast, and you don’t have to have gotten in early on SpaceX to profit. This report shows seven space stocks you can buy today that may grow as rockets, satellites, defense, space internet, and new space technology become more important.Get This Free Report This page (OTCMKTS:OMGAQ) was last updated on 9/28/2026 by MarketBeat.com Staff. From Our PartnersElon Musk’s Hushed FCC Filing. Dec 8th.Elon Musk quietly filed a document with the federal government tied to artificial intelligence, one of the lar...Paradigm Press | SponsoredHere’s the stock symbol I’ve promisedWhitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...Stansberry Research | SponsoredTrump's New DollarPorter Stansberry says President Trump has signed an executive order initiating what he calls a full U.S. doll...Porter & Company | SponsoredThe next convergence is hereIn 2006, a flooded mine at Cigar Lake sent uranium prices from the 50 range to 136 in eight months. This pa...Digest Publishing | SponsoredManagement just bought 2.8 million sharesManagement just backed a $100 million buyback, repurchasing 2.8 million shares at an average price of $35.26 i...Monument Traders Alliance | SponsoredThis AI Stock Reminds One Analyst of Early NvidiaJeff Brown picked Nvidia in 2016, before shares surged 37,800 percent. Now he's identified another AI company ...Brownstone Research | SponsoredMajor Buy Alert Issued for September 30thKeith Kaplan has invested $17 million into his own AI research tools, building a platform now used by 180,000 ...TradeSmith | SponsoredWhy major institutions are piling into this digital asset nowBlackRock, JPMorgan, Goldman Sachs, and Fidelity are reportedly accumulating a scarce blockchain asset - one t...Awesomely | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Omega Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Omega Therapeutics With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
